Bloomage
Bloomage
Bloomage BioTechnology is a injectable hyaluronan soft tisse filling gel
Bloomage, founded in January, 2000 and headquartered in Jinan, is a hyaluronic acid R&D manufacturer. The founder is Zhao Yan. Listed on the SSE on November 6, 2019, the company's major shareholders are Huaxi Xinyu Investment Co., Ltd., China Life Chengda (Shanghai) Health Industry Equity Investment Center (LP) and Ningxia Yingrui Wuyuan PE Partnership Enterprise (LP). Rivals that have direct and indirect competition with Bloomage include Well, Boai Nky, Pharm Agra, Mylan, etc.
- All
- News
- Analysis
- Research
Briefing Feb 01, 2021 02:41 PM
· Healthcare
Bh009 new drug project independently researched and developed by Beihai biological Co., Ltd. was approved by China's clinical trials
Briefing Jan 08, 2021 11:30 AM
· Healthcare
Xinyi biological completed 150 million round B financing, and Lilly Asia Fund led investment in Huachuang capital, hillhood venture capital and other follow-up investment
In depth
Briefing Dec 30, 2020 05:28 PM
· Healthcare
Another protein component special medical food was approved, and the total number of approved products increased to 57
Briefing Dec 28, 2020 02:44 PM
· Healthcare
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Dec 09, 2020 08:55 AM
Research
Real Estate, Consumer Discretionary, Consumer StaplesTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Briefing Dec 02, 2020 11:21 AM
· Healthcare
Improving service quality and enabling industrial innovation!
Briefing Nov 17, 2020 08:04 PM
· Healthcare
Plan to raise $4 billion! Jingdong health runs IPO
Briefing Nov 11, 2020 10:42 AM
· Healthcare
Drug Innovator Asieris Nabs CNY 700 Million Series D
Briefing Nov 03, 2020 12:06 PM
· Healthcare
HaoYuan Chemexpress Files for IPO on the Star Market
Healthcare
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
Real Estate, Healthcare, Automotive
WIM2020: Uniting the World through Technology and Innovation
On December 9-12, EqualOcean held the World Innovators Meet (WIM) 2020. This year, the event's main topic was 'Technology and Innovation Connect the World.' WIM2020 gathered innovators from Asia, Africa, Europe and North America to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 17, 2020 07:53 PM
Briefing Oct 16, 2020 04:24 PM
· Healthcare
Beijing Immunochina Pharmaceutical Closes Series C+ at CNY 100 Mn
Briefing Sep 28, 2020 08:25 PM
· Healthcare
Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq
Briefing Sep 28, 2020 12:12 PM
· Healthcare
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
Healthcare
EqualOcean Presents Next 50 in Global Tech: Healthcare (WIA2020)
On December 9-12, EqualOcean is holding the World Innovators Meet (WIM) 2020. This year, the event's main topic is 'Technology and Innovation Connect the World.' WIM2020 gathers innovators from Asia, Africa, Europe and the Americas to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 11, 2020 07:35 PM
Briefing Sep 28, 2020 10:49 AM
· Healthcare
Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars
Briefing Sep 23, 2020 11:37 AM
· Healthcare
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Briefing Sep 23, 2020 11:11 AM
· Healthcare
Tongshu Gene Closes Series B of Multi-Hundreds Millions
Briefing Sep 22, 2020 12:23 PM
· Healthcare
Medical Cosmetic Manufacture IMEIK Goes Public, Raising CNY 3.57 Bn
See more
Related Companies
EqualOcean Analysis
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- China Speed: Two COVID-19 Vaccines Recognized by WHO
- After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
- Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
- More Room for the Medical Device Market to Grow in China
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.